SCHEMBL10329448

SCHEMBL10329448

CC1(CCCn2c(=O)n(CCCC3(C)CO3)c(=O)n(CCCC3(C)CO3)c2=O)CO1

nearest known ligand 0.38

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.30
HBB P68871 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
HIF1A Q16665 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17983112 0.77 MEN1 (0.40) SMN1; SMN2KDM4EALDH1A1LMNA
SCHEMBL17983214 0.76 MGLL (0.52) TP53SMN1; SMN2ALDH1A1LMNA
SCHEMBL10329449 0.74 TP53 (0.33) TP53HBBSMN1; SMN2
SCHEMBL6153134 0.74 TP53 (0.34) TP53HBBSMN1; SMN2
SCHEMBL12040249 0.72 HTT (0.33) TP53HBBSMN1; SMN2KDM4EALDH1A1
SCHEMBL17983066 0.71 CYP1A2 (0.54)
SCHEMBL13294287 0.70
SCHEMBL17983257 0.70 CYP1A2 (0.31)
SCHEMBL17983341 0.68 MEN1 (0.34) ALDH1A1
SCHEMBL17983127 0.67 MGLL (0.45) TP53SMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10005742-B2 Method for producing epoxy compound containing hydrogen peroxide stabilizer NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2018-06-26 US disclosed
US-10005742-B2 Method for producing epoxy compound containing hydrogen peroxide stabilizer NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2018-06-26 US disclosed
US-20170275258-A1 METHOD FOR PRODUCING EPOXY COMPOUND CONTAINING HYDROGEN PEROXIDE STABILIZER NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-09-28 US disclosed
US-20170275258-A1 METHOD FOR PRODUCING EPOXY COMPOUND CONTAINING HYDROGEN PEROXIDE STABILIZER NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-09-28 US disclosed
US-9464074-B2 Method for producing epoxy compound NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-10-11 US disclosed
US-9464074-B2 Method for producing epoxy compound NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-10-11 US disclosed
US-20150284372-A1 METHOD FOR PRODUCING EPOXY COMPOUND NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2015-10-08 US disclosed
US-20150284372-A1 METHOD FOR PRODUCING EPOXY COMPOUND NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2015-10-08 US disclosed
EP-2913331-A1 METHOD FOR PRODUCING EPOXY COMPOUND Nissan Chemical Industries, Ltd. (JP) 2015-09-02 EP disclosed
US-8221965-B2 Antireflective coating compositions AZ ELECTRONIC MATERIALS USA CORP. (US) 2012-07-17 US disclosed
US-8221965-B2 Antireflective coating compositions AZ ELECTRONIC MATERIALS USA CORP. (US) 2012-07-17 US disclosed
US-20100009293-A1 Antireflective Coating Compositions MERCK PATENT GMBH (DE) 2010-01-14 US disclosed
US-20100009293-A1 Antireflective Coating Compositions MERCK PATENT GMBH (DE) 2010-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275258-A1 METHOD FOR PRODUCING EPOXY COMPOUND CONTAINING HYDROGEN PEROXIDE STABILIZER GPX4, HAO2, HPD TP53 3975/4885HBB 4313/4885SMN1; SMN2 3675/4885
US-10005742-B2 Method for producing epoxy compound containing hydrogen peroxide stabilizer GPX4, HAO2, HPD TP53 3975/4885HBB 4313/4885SMN1; SMN2 3675/4885
US-20150284372-A1 METHOD FOR PRODUCING EPOXY COMPOUND NOX5, NOX4, NOXO1 TP53 4678/4885HBB 3519/4885SMN1; SMN2 3387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.